glp 1 for chronic inflammation Health Feed The expanding landscape of GLP-1

WEDNESDAY, June 10, 2026 (HealthDay News) -- Continuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) into early pregnancy seems not to be associat

Consume Protein-Rich Foods Protein promotes GLP-1 secretion, aiding satiety and blood sugar control

The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status

Whenever a pharmaceutical breakthrough fundamentally changes the treatment of a widespread disease, the same question inevitably arises: how should the law balance the protection of innovation against the need to ensure access to essential medicines?Africa is no stranger to this dilemma

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

USA shipped.